Wordle Today: Wordle answer and hints for March 24
Trying to solve the Wordle today? If you're stuck, we've got a few hints that will help you keep your Wordle streak alive.The ...
Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market
Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.70% to $511.74 Monday, on what proved to be an all-around great trading ...
Stifel Nicolaus Remains a Hold on Vertex (VERX)
Stifel Nicolaus analyst Brad Reback maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $31.00. The ...
Vertex price target raised to $60 from $57 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...
Seeking Alpha2d
VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
pharmaphorum1d
Vertex buys diabetes cell therapy rival ViaCyte for $320m
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Yahoo Finance5d
Vertex Pharmaceuticals Incorporated (VRTX)
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.
Yahoo Finance2d
Vertex Pharmaceuticals Incorporated (VRTX)
After hours: March 24 at 7:44:11 PM EDT Loading Chart for VRTX ...